These observations supported our hypothesis that the nanoassembly-mediated cooperative DC-specific cGAS-STING stimulation and tumor-selective ICD induction was beneficial for activating robust tumor-specific T cell immunity against metastatic tumors. The gene discussed is STING1; the disease is neoplasm.